What is she best known for?
The fields of study she is best known for:
- Dopamine
- Neuron
- Neurotransmitter
Barbara Picconi spends much of her time researching Neuroscience, Synaptic plasticity, Long-term potentiation, Dopamine and Striatum.
Her work deals with themes such as NMDA receptor and Dyskinesia, Parkinson's disease, which intersect with Neuroscience.
Her Neurotransmission research extends to the thematically linked field of Synaptic plasticity.
Her Long-term potentiation research incorporates themes from Glutamate receptor, Long-term depression and Abnormal involuntary movement.
Her research in Dopamine intersects with topics in Lesion and Denervation.
The various areas that Barbara Picconi examines in her Striatum study include Basal ganglia and Glutamatergic.
Her most cited work include:
- Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia (673 citations)
- Dopamine-mediated regulation of corticostriatal synaptic plasticity (606 citations)
- Direct and indirect pathways of basal ganglia: a critical reappraisal (398 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Neuroscience, Synaptic plasticity, Long-term potentiation, Dopamine and Striatum.
Her Neuroscience study combines topics from a wide range of disciplines, such as NMDA receptor and Dyskinesia, Parkinson's disease.
Her Synaptic plasticity research includes themes of Hippocampus, Dopamine receptor D2 and Long-term depression.
Her studies deal with areas such as Depotentiation, Neurotransmission and Abnormal involuntary movement as well as Long-term potentiation.
Her Dopamine study integrates concerns from other disciplines, such as Stimulation, Neurotransmitter and Denervation.
Her Striatum study incorporates themes from Glutamate receptor, Glutamatergic, Basal ganglia and Cholinergic.
She most often published in these fields:
- Neuroscience (79.07%)
- Synaptic plasticity (44.96%)
- Long-term potentiation (37.98%)
What were the highlights of her more recent work (between 2014-2020)?
- Neuroscience (79.07%)
- Dopamine (34.88%)
- Parkinson's disease (27.91%)
In recent papers she was focusing on the following fields of study:
Barbara Picconi mostly deals with Neuroscience, Dopamine, Parkinson's disease, Long-term potentiation and Synaptic plasticity.
The Neuroscience study combines topics in areas such as Levodopa, Dyskinesia, Levodopa-induced dyskinesia and NMDA receptor.
Her Dopamine research focuses on Midbrain and how it connects with Microglia and Neuron.
Her biological study spans a wide range of topics, including Striatum, Neurodegeneration and Neuroinflammation.
Her Long-term potentiation research is multidisciplinary, incorporating perspectives in Medium spiny neuron, Hippocampus and Direct pathway of movement.
She interconnects Transcranial magnetic stimulation, Dopamine receptor D2, Neuropathology, Neuroplasticity and Long-term depression in the investigation of issues within Synaptic plasticity.
Between 2014 and 2020, her most popular works were:
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. (244 citations)
- Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts. (89 citations)
- Early synaptic dysfunction in Parkinson's disease: Insights from animal models (70 citations)
In her most recent research, the most cited papers focused on:
- Neuron
- Neurotransmitter
- Dopamine
Her primary areas of study are Neuroscience, Synaptic plasticity, Dyskinesia, Parkinson's disease and Dopamine.
Her studies in Neuroscience integrate themes in fields like Levodopa and Long-term potentiation.
Her research integrates issues of Substantia nigra, Transcranial magnetic stimulation and Axoplasmic transport in her study of Synaptic plasticity.
She combines subjects such as Deep brain stimulation, Excitatory postsynaptic potential, Dystonia, Neuroplasticity and Movement disorders with her study of Dyskinesia.
Her work in the fields of Parkinson's disease, such as Pars compacta, overlaps with other areas such as Synaptopathy.
Barbara Picconi interconnects Midbrain, Degeneration, Inflammation, Microglia and Neuron in the investigation of issues within Dopamine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
